Platelet activation and interactions with the microvasculature

Journal of Cardiovascular Pharmacology

Volumn 27, Issue SUPPL. 1, 1996, Pages

  Body, Simon C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anticoagulation; Coagulation; Endothelium; Platelet adhesion

Indexed keywords

ANTICOAGULANT AGENT; APYRASE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; CELL ADHESION MOLECULE; COLLAGEN; ENDOTHELIN; ENDOTHELIUM DERIVED RELAXING FACTOR; FIBRINOGEN; FIBRONECTIN; GLYCOPROTEIN; HEPARIN; HIGH MOLECULAR WEIGHT KININOGEN; INTEGRIN; LAMININ; NITRIC OXIDE; PROSTACYCLIN; RECEPTOR PROTEIN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOMODULIN; THROMBOPLASTIN; THROMBOSPONDIN; THROMBOXANE A2; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; BLOOD VESSEL INJURY; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REPERFUSION INJURY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 0030049759     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199600001-00006     Document Type: Conference Paper

References (77)

1. Florey L. The endothelial cell. BMJ 1966;2:487-90.
2. Furchgott RF, Zawadski JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;299:373-6.
3. Palmer RMJ, Ferringe AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
4. Ignarro LJ, Buga GM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9.
5. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrate: the basis for the proposal that the acid-activatable component of inhibitory factor from retractor penis is inorganic nitrate and endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM, ed. Vasodilation: vascular smooth muscle, peptides, autonomic nerves and endothelium. 4th International Symposium on Mechanisms of Vasodilatation, 1986. New York: Raven Press, 1988:401-14.
6. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992;89:7674-7.
7. Ignarro LJ, Fukuto JM, Griscavagne JM, et al. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from 1-arginine. Proc Natl Acad Sci USA 1993;90:8103-7.
8. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide production. Potential relevance to cardiovascular disease. Circ Res 1993;73:217-22.
9. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-7.
10. Muruganandam A, Mutus B. Isolation of nitric oxide synthase from human platelets. Biochim Biophys Acta 1994;1200:1-6.
11. Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. In: Authi KS, Watson SP, Kakkar VV, eds. Mechanisms of platelet activation and control. New York: Plenum Press, 1993:251-64.
12. Yui Y, Hattori R, Kunihiko K, et al. Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils. J Biol Chem 1991;270:833-6.
13. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon "gamma" in combination with tumor necrosis factor, interleukin-1 or endotoxin. J Natl Cancer Inst 1990;82:772-6.
14. Broekman MJ, Eiroa AM, Marcus AJ. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood 1991;78:1033-40.
15. de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992;85:2284-90.
16. Walter U, Eigenthaler M, Geiger J, Reinhard M. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. In: Authi KS, Watson SP, Kakkar VV, eds. Mechanisms of platelet activation and control. New York: Plenum Press, 1993:237-49.
17. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
18. Radomski MW, Palmer RM, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148:1482-9.
19. Durante W, Kroll MH, Vanhoutte PM, et al. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting phospholipase C. Blood 1992;79: 110-6.
20. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994;89:2035-40.
21. Dembinska KA, Zmuda A, Wenhrynowicz O, Stachura J, Peskar BA, Gryglewski RJ. Selectin-P-mediated adherence of platelets to neutrophils is regulated by prostanoids and nitric oxide. Int J Tissue React 1993;15:55-64.
22. Gerg JG, Bevilaqua MP, Moore KI, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP 140. Nature 1990;343:757-60.
23. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
24. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994;107: 1050-8.
25. Larsen E, Celi A, Gilbert GE, et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and macrocytes. Cell 1989;59:305-12.
26. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550-4.
27. McEver RP. Role of selectins in leukocyte adhesion to platelets and endothelium. Ann NY Acad Sci 1994;714:185-9.
28. Nguyen BL, Saitoh M, Ware JA. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 1991;261:h1043-52.
29. Pohl U, Busse R. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed. Circ Res 1989;65:1798-803.
30. Maurice DH, Haslam RJ. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 1990;37:671-81.
31. Watson SP, McConnell RT, Lapetina EG. The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J Biol Chem 1984;259:13199-203.
32. Johnson PC, Ware JA, Salzman EW. Concurrent measurement of platelet ionized calcium concentration and aggregation: studies with the lumiaggregometer. Thromb Res 1985;40: 435-43.
33. Moncada S. The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992;145:201-27.
34. Simon DI, Stamler JS, Jaraki O, et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb 1993;13: 791-9.
35. Mellion BT, Ignarro LJ, Ohlstein EH, et al. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981;57:946-55.
36. Buechler WA, Ivanova K, Wolfram G, Drummer C, Heim JM, Gerzer R. Soluble guanylyl cyclase and platelet function. Ann NY Acad Sci 1994;714:151-7.
37. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988;93:515-24.
38. Mugge A, Lopez JA, Piegors DJ, Breese KR, Heistad DD. Acetylcholine-induced vasodilatation in rabbit hindlim in vivo is not inhibited by analogues of L-arginine. Am J Physiol 1991;260:H242-7.
39. Marcus AJ, Weksler BB, Jaffe FA, Broekman MJ. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured cells. J Clin Invest 1980;66:979-86.
40. Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989;74:1181-95.
41. Hawiger J, Parkinson S, Timmons S. Prostacyclin inhibits mobilization of fibrinogen binding sites on human ADP and thrombin-treated platelets. Nature 1980;283:195-8.
42. Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI. Plasma's effect on platelets glycoprotein Ib-von Willebrand factor interactions. Blood 1985;65:32-40.
43. Stamler JS, Simon DI, Jaraki O, et al. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl Acad Sci USA 1992;89: 8087-91.
44. Marcus AJ, Safier LB, Hajjar KA, et al. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest 1991;88: 1690-6.
45. Szabó CS, Wu CC, Mitchell JA, et al. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 1993;73:991-9.
46. Booth NA, Anderson JA, Bennett B. Platelet release protein which inhibits plasminogen activators. J Clin Pathol 1985;38: 825-30.
47. Dockrell ME, Haynes WG, Williams BC, Webb DJ. Endothelin-1 and aggregation of human platelets in vitro. J Cardiovasc Pharmacol 1993;22:S204-6.
48. Kato K, Sawada S, Toyoda T, et al. Influence of endothelin on human platelet aggregation and prostacyclin generation from human vascular endothelial cells in culture. Jpn Circ J 1992;56:422-31.
49. Ordinas A, Escolar G, White JG. Ultrastructure of platelets and platelet-surface interactions. In: Missirlis YF, Wautier J-L, eds. The role of platelets in blood-biomaterial interactions. Dordrecht: Kluwer Academic Publishers, 1993:3-13.
50. Stel HV, Sakariassen KS, de Groot PG, van Mourik JA, Sixma JJ. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood 1985;65:85-90.
51. Newman PJ, Berndt NC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene super family. Science 1990;247:1219-22.
52. King M, McDermott P, Schreiber AD. Characterization of the Fc gamma receptor on human platelets. Cell Immunol 1990;128:462-79.
53. McEver RP. Leukocyte interaction mediated by selectins. Thromb Haemost 1991;66:80-7.
54. Sims PJ, Ginsberg MH, Plow EF, Shattil SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa receptor. J Biol Chem 1991;266:7345-52.
55. Roth GJ. Developing relationships: arterial platelet adhesion, glycoprotein Ib and leucine-rich glycoproteins. Blood 1991;77: 5-19.
56. Fox JEB. Regulation of platelet function by the cytoskeleton. In: Authi KS, Watson SP, Kakkar VV, eds. Mechanisms of platelet activation and control. New York: Plenum Press, 1993: 175-85.
57. Agbanyo FR, Sixma JJ, de GP, Languino LR, Plow EF. Thrombospondin-platelet interactions. Role of divalent cat-ions, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 1993;92:288-96.
58. Rittenhouse S. Human platelets contain phospholipase C that hydrolyses polyphosphoinositides. Proc Natl Acad Sci USA 1983;80:5417-20.
59. 2+-transporting membrane vesicle fraction derived from human platelets. J Biol Chem 1985;260:956-62.
60. Moore KL, Stults NL, Diaz S, et al. Identification of a specific glycoprotein ligand for P-selectin (CD-62) on myeloid cells. J Cell Biol 1992;118:445-56.
61. Turitto VT, Weiss HJ. Rheological factors influencing platelet interaction with vessel surfaces. J Rheol 1979;23:735-49.
62. Packham MA, Mustard JF. Platelet adhesion. Prog Hemost Thromb 1984;7:211-88.
63. de Groot PG, Sixma JJ. Platelet adhesion. Br J Haematol 1990;75:308-12.
64. Faint RW. Platelet-neutrophil interactions: their significance. Blood Rev 1992;6:83-91.
65. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 1993;265(3 pt 2):h862-7.
66. Santos MT, Valles J, Marcus AJ, et al. Contrasting effects of 12- and 5-lipoxygenase products in the inhibition of human platelet reactivity by neutrophils [Abstract]. Clin Res 1991;39: 254a.
67. Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. Am J Physiol 1990;258: C1100-7.
68. Cerletti C, Evangilista V, Molino M, Piccardoni P, Maugeri N, de Gaetano G. Polymorphonuclear leukocytes modulate platelet function. In: Missirilis YF, Wautier J-L, eds. The role of platelets in blood-biomaterial interactions. Dordrecht: Kluwer Academic Publishers, 1993:95-106.
69. Jen CI, McIntire LV. Characteristics of shear-induced aggregation in whole blood. J Lab Clin Med 1984;103:115-8.
70. Badimon L, Chesebro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 1992;86(suppl 6):iII74-85.
71. Weyrich AS, Ma X-L, Lefer DJ, et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91: 2620-9.
72. Kanwar S, Kubes P. Mast cells contribute to ischemia/reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am J Physiol 1994;267:G316-21.
73. Hernandez LA, Grisham MB, Twohig B, et al. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1994;259:G300-5.
74. Ma X-L, Weyrich AS, Lefer DJ, et al. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-12.
75. Van Benthuysen KM, McMurtry IF, Horowitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelial-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 1987;79:265-74.
76. Kubes P, Kurose I, Granger DN. Nitric oxide donors prevent integrin-induced leukocyte adhesion, but not P-selectin-dependent rolling in post-ischemic venules. Am J Physiol 1994;267: H931-7.
77. Tsao PS, Aoki N, Lefer DJ, et al. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion. Circulation 1990;82:1402-12.